Istituti Clinici Scientifici Maugeri, IRCCS, Psychology Unit of Montescano Institute, Pavia, Italy.
Istituti Clinici Scientifici Maugeri, IRCCS, Cardiac Rehabilitation Division of Tradate Institute, Varese, Italy.
PLoS One. 2022 Aug 4;17(8):e0272132. doi: 10.1371/journal.pone.0272132. eCollection 2022.
Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are two clinical conditions often associated with functional worsening, cognitive dysfunctions, treatment non-adherence, psychological distress and poor quality of life (QoL). In addition, since patients suffering from these conditions are often older adults, the presence of frailty syndrome could worsen the clinical situation.
This study protocol of a prospective multi-center clinical trial, will be conducted at two hospitals of the Istituti Clinici Scientifici Maugeri IRCCS group, from July 2020 until December 2022. CHF and COPD older patients (age ≥65) will undergo a multidisciplinary assessment at admission, discharge and at 6 months follow-up, from an inpatient rehabilitation program: disease-related clinical characteristics, functional variables, cognitive screening, treatment adherence, anxiety, depression, QoL and frailty. The estimated sample size will consist of 300 patients.
The expected results are related to the possibility of an improvement in the areas of intervention after the rehabilitative program and the maintenance of these improvements over time. The assessment of clinical and functional status, cognitive impairment, treatment adherence, psychosocial characteristics, and frailty could provide more specific and useful information about the main features to be considered in the evaluation and treatment of older patients suffering from CHF and COPD undergoing a rehabilitative pathway.
The study has been registered on January 28, 2022 with the ClinicalTrials.gov NCT05230927 registration number (clinicaltrials.gov/ct2/show/NCT05230927).
慢性心力衰竭(CHF)和慢性阻塞性肺疾病(COPD)是两种常伴有功能恶化、认知功能障碍、治疗不依从、心理困扰和生活质量(QoL)下降的临床病症。此外,由于患有这些病症的患者通常是老年人,衰弱综合征的存在可能会使临床状况恶化。
本研究是一项前瞻性多中心临床试验的方案,将于 2020 年 7 月至 2022 年 12 月在 Istituti Clinici Scientifici Maugeri IRCCS 集团的两家医院进行。CHF 和 COPD 老年患者(年龄≥65 岁)将在入院时、出院时和 6 个月随访时接受多学科评估,评估内容包括与疾病相关的临床特征、功能变量、认知筛查、治疗依从性、焦虑、抑郁、QoL 和衰弱。预计样本量为 300 例患者。
预期结果与康复计划后干预领域的改善以及这些改善随时间的维持有关。临床和功能状况、认知障碍、治疗依从性、心理社会特征和衰弱的评估可以提供更具体和有用的信息,这些信息与评估和治疗正在接受康复途径的 CHF 和 COPD 老年患者的主要特征有关。
该研究于 2022 年 1 月 28 日在 ClinicalTrials.gov 注册,注册号为 NCT05230927(clinicaltrials.gov/ct2/show/NCT05230927)。